Johnson & Johnson (JNJ) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Johnson & Johnson (JNJ) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

JNJ

Market Closed

Johnson & Johnson

NYSEHealthcare Drug Manufacturers - General

138.10K employees

CEO: Joaquin Duato

Founded: 1943

$228.39

+$0.00(+NaN%)

Market Cap

549.78B

Beta

0.26

52W Range

N/A

Dividend Yield

2.29%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

72.8%

11.7%

CAGR: 5.5%

Profit after direct costs

Operating Margin

27.2%

15.6%

CAGR: 5.1%

Core business profitability

Net Margin

28.5%

90.6%

CAGR: 6.4%

Bottom line profitability

Revenue Growth

6.0%

YoY

CAGR: 4.6%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how JNJ allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

72.8%

$68.56B

Operating Margin

27.2%

$25.60B

Net Margin

28.5%

$26.80B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	78.74B	79.99B	85.16B	88.82B	94.19B	6.0%
Cost of Revenue	(23.40B)	(24.60B)	(26.55B)	(27.47B)	(25.64B)	-6.7%
Gross Profit	55.34B	55.39B	58.61B	61.35B	68.56B	11.7%
Operating Expenses
Research & Development	(14.28B)	(14.13B)	(15.09B)	(17.23B)	(14.66B)	-14.9%
Selling, General & Administrative	(20.12B)	(20.25B)	(20.11B)	(21.97B)	(23.68B)	7.8%
General & Administrative	(20.12B)	(20.25B)	(20.11B)	(21.97B)	(23.68B)	7.8%
Depreciation & Amortization	(7.39B)	(6.97B)	(7.49B)	(7.34B)	(7.50B)	2.2%
Operating Income (EBIT)	20.94B	21.01B	23.41B	22.15B	25.60B	15.6%
Non-Operating Items
Interest Income	53.00M	490.00M	1.26B	1.33B	1.06B	-20.7%
Interest Expense	(183.00M)	(276.00M)	(772.00M)	(755.00M)	(971.00M)	28.6%
Other Income/Expenses (Net)	-1.76B	-1.65B	-8.35B	-5.46B	6.99B	-227.9%
Income Before Tax	19.18B	19.36B	15.06B	16.69B	32.58B	95.2%
Income Tax Expense	(1.38B)	(2.99B)	(1.74B)	(2.62B)	(5.78B)	120.4%
Net Income	20.88B	17.94B	35.15B	14.07B	26.80B	90.6%
Per Share Metrics
Earnings Per Share (Basic)	$8	$7	$14	$6	$11	88.9%
Weighted Avg Shares Outstanding	2.63B	2.61B	2.53B	2.41B	2.43B	0.9%
Weighted Avg Shares Outstanding (Diluted)	2.67B	2.66B	2.56B	2.43B	2.43B	0.0%
EBITDA	26.75B	26.61B	23.32B	24.78B	41.05B	65.7%

Explore JNJ

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

JNJ in the Healthcare

Mega Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →